nodes	percent_of_prediction	percent_of_DWPC	metapath
Aztreonam—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00187	0.00187	CcSEcCtD
Aztreonam—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Aztreonam—Discomfort—Cisplatin—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Aztreonam—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Aztreonam—Urticaria—Thiotepa—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Aztreonam—Malaise—Etoposide—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Aztreonam—Vertigo—Etoposide—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Aztreonam—Abdominal pain—Thiotepa—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Aztreonam—Body temperature increased—Thiotepa—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Aztreonam—Purpura—Doxorubicin—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Aztreonam—Hypotension—Gemcitabine—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Aztreonam—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Aztreonam—Hypotension—Fluorouracil—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Aztreonam—Cough—Etoposide—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Aztreonam—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Aztreonam—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Aztreonam—Convulsion—Etoposide—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Aztreonam—Insomnia—Gemcitabine—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Aztreonam—Diplopia—Doxorubicin—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Aztreonam—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Aztreonam—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Aztreonam—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Aztreonam—Chest pain—Etoposide—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Aztreonam—Eosinophilia—Methotrexate—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Aztreonam—Insomnia—Fluorouracil—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Aztreonam—Paraesthesia—Fluorouracil—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Aztreonam—Discomfort—Etoposide—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Aztreonam—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Aztreonam—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Aztreonam—Hypotension—Cisplatin—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Aztreonam—Confusional state—Etoposide—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Aztreonam—Pain—Gemcitabine—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Aztreonam—Pancytopenia—Methotrexate—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Aztreonam—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Aztreonam—Asthenia—Thiotepa—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Aztreonam—Abdominal distension—Epirubicin—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Aztreonam—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Aztreonam—Neutropenia—Methotrexate—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Aztreonam—Pruritus—Thiotepa—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Aztreonam—Pain—Fluorouracil—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Aztreonam—Paraesthesia—Cisplatin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Aztreonam—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Aztreonam—Eosinophilia—Epirubicin—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Aztreonam—Dyspnoea—Cisplatin—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Aztreonam—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Aztreonam—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Aztreonam—Diarrhoea—Thiotepa—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Aztreonam—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Aztreonam—Pancytopenia—Epirubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Aztreonam—Hypotension—Etoposide—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Aztreonam—Pain—Cisplatin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Aztreonam—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Aztreonam—Neutropenia—Epirubicin—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Aztreonam—Dizziness—Thiotepa—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Aztreonam—Abdominal distension—Doxorubicin—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Aztreonam—Stomatitis—Methotrexate—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Aztreonam—Urticaria—Fluorouracil—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Aztreonam—Body temperature increased—Fluorouracil—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Aztreonam—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Aztreonam—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Aztreonam—Paraesthesia—Etoposide—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Aztreonam—Dyspnoea—Etoposide—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Aztreonam—Vomiting—Thiotepa—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Aztreonam—Rash—Thiotepa—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Aztreonam—Dermatitis—Thiotepa—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Aztreonam—Headache—Thiotepa—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Aztreonam—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Aztreonam—Body temperature increased—Cisplatin—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Aztreonam—Jaundice—Epirubicin—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Aztreonam—Stomatitis—Epirubicin—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Aztreonam—Pain—Etoposide—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Aztreonam—Neutropenia—Doxorubicin—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Aztreonam—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Aztreonam—Haemoglobin—Methotrexate—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Aztreonam—Haemorrhage—Methotrexate—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Aztreonam—Hepatitis—Methotrexate—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Aztreonam—Asthenia—Gemcitabine—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Aztreonam—Pruritus—Gemcitabine—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Aztreonam—Nausea—Thiotepa—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Aztreonam—Feeling abnormal—Etoposide—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Aztreonam—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Aztreonam—Pruritus—Fluorouracil—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Aztreonam—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Aztreonam—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Aztreonam—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Aztreonam—Urticaria—Etoposide—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Aztreonam—Haemoglobin—Epirubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Aztreonam—Stomatitis—Doxorubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Aztreonam—Jaundice—Doxorubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Aztreonam—Abdominal pain—Etoposide—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Aztreonam—Body temperature increased—Etoposide—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Aztreonam—Haemorrhage—Epirubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Aztreonam—Hepatitis—Epirubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Aztreonam—Diarrhoea—Fluorouracil—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Aztreonam—Tinnitus—Methotrexate—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Aztreonam—Asthenia—Cisplatin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Aztreonam—Dizziness—Fluorouracil—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Aztreonam—Diarrhoea—Cisplatin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Aztreonam—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Aztreonam—Vomiting—Gemcitabine—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Aztreonam—Rash—Gemcitabine—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Aztreonam—Dermatitis—Gemcitabine—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Aztreonam—Hypersensitivity—Etoposide—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Aztreonam—Tinnitus—Epirubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Aztreonam—Erythema—Methotrexate—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Aztreonam—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Aztreonam—Headache—Gemcitabine—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Aztreonam—Flushing—Epirubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Aztreonam—Vomiting—Fluorouracil—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Aztreonam—Hepatitis—Doxorubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Aztreonam—Haemorrhage—Doxorubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Aztreonam—Rash—Fluorouracil—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Aztreonam—Dermatitis—Fluorouracil—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Aztreonam—Headache—Fluorouracil—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Aztreonam—Dysgeusia—Methotrexate—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Aztreonam—Asthenia—Etoposide—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Aztreonam—Pruritus—Etoposide—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Aztreonam—Nausea—Gemcitabine—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Aztreonam—Vomiting—Cisplatin—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Aztreonam—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Aztreonam—Rash—Cisplatin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Aztreonam—Dermatitis—Cisplatin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Aztreonam—Erythema—Epirubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Aztreonam—Diarrhoea—Etoposide—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Aztreonam—Nausea—Fluorouracil—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Aztreonam—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Aztreonam—Tinnitus—Doxorubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Aztreonam—Anaemia—Methotrexate—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Aztreonam—Flushing—Doxorubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Aztreonam—Dysgeusia—Epirubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Aztreonam—Malaise—Methotrexate—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Aztreonam—Dizziness—Etoposide—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Aztreonam—Vertigo—Methotrexate—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Aztreonam—Nausea—Cisplatin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Aztreonam—Cough—Methotrexate—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Aztreonam—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Aztreonam—Convulsion—Methotrexate—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Aztreonam—Vomiting—Etoposide—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Aztreonam—Erythema—Doxorubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Aztreonam—Anaemia—Epirubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Aztreonam—Rash—Etoposide—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Aztreonam—Dermatitis—Etoposide—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Aztreonam—Headache—Etoposide—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Aztreonam—Myalgia—Methotrexate—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Aztreonam—Chest pain—Methotrexate—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Aztreonam—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Aztreonam—Malaise—Epirubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Aztreonam—Discomfort—Methotrexate—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Aztreonam—Vertigo—Epirubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Aztreonam—Confusional state—Methotrexate—urinary bladder cancer	0.000996	0.000996	CcSEcCtD
Aztreonam—Cough—Epirubicin—urinary bladder cancer	0.000988	0.000988	CcSEcCtD
Aztreonam—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000987	0.000987	CcSEcCtD
Aztreonam—Convulsion—Epirubicin—urinary bladder cancer	0.000981	0.000981	CcSEcCtD
Aztreonam—Nausea—Etoposide—urinary bladder cancer	0.000979	0.000979	CcSEcCtD
Aztreonam—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000972	0.000972	CcSEcCtD
Aztreonam—Anaemia—Doxorubicin—urinary bladder cancer	0.000968	0.000968	CcSEcCtD
Aztreonam—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000967	0.000967	CcSEcCtD
Aztreonam—Chest pain—Epirubicin—urinary bladder cancer	0.000964	0.000964	CcSEcCtD
Aztreonam—Myalgia—Epirubicin—urinary bladder cancer	0.000964	0.000964	CcSEcCtD
Aztreonam—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000955	0.000955	CcSEcCtD
Aztreonam—Discomfort—Epirubicin—urinary bladder cancer	0.000952	0.000952	CcSEcCtD
Aztreonam—Malaise—Doxorubicin—urinary bladder cancer	0.000945	0.000945	CcSEcCtD
Aztreonam—Vertigo—Doxorubicin—urinary bladder cancer	0.000941	0.000941	CcSEcCtD
Aztreonam—Confusional state—Epirubicin—urinary bladder cancer	0.000932	0.000932	CcSEcCtD
Aztreonam—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000924	0.000924	CcSEcCtD
Aztreonam—Hypotension—Methotrexate—urinary bladder cancer	0.000923	0.000923	CcSEcCtD
Aztreonam—Cough—Doxorubicin—urinary bladder cancer	0.000914	0.000914	CcSEcCtD
Aztreonam—Convulsion—Doxorubicin—urinary bladder cancer	0.000908	0.000908	CcSEcCtD
Aztreonam—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000905	0.000905	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.0009	0.0009	CcSEcCtD
Aztreonam—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000893	0.000893	CcSEcCtD
Aztreonam—Insomnia—Methotrexate—urinary bladder cancer	0.000893	0.000893	CcSEcCtD
Aztreonam—Myalgia—Doxorubicin—urinary bladder cancer	0.000892	0.000892	CcSEcCtD
Aztreonam—Chest pain—Doxorubicin—urinary bladder cancer	0.000892	0.000892	CcSEcCtD
Aztreonam—Paraesthesia—Methotrexate—urinary bladder cancer	0.000887	0.000887	CcSEcCtD
Aztreonam—Discomfort—Doxorubicin—urinary bladder cancer	0.000881	0.000881	CcSEcCtD
Aztreonam—Dyspnoea—Methotrexate—urinary bladder cancer	0.00088	0.00088	CcSEcCtD
Aztreonam—Hypotension—Epirubicin—urinary bladder cancer	0.000863	0.000863	CcSEcCtD
Aztreonam—Confusional state—Doxorubicin—urinary bladder cancer	0.000862	0.000862	CcSEcCtD
Aztreonam—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000855	0.000855	CcSEcCtD
Aztreonam—Pain—Methotrexate—urinary bladder cancer	0.000844	0.000844	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000842	0.000842	CcSEcCtD
Aztreonam—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000837	0.000837	CcSEcCtD
Aztreonam—Insomnia—Epirubicin—urinary bladder cancer	0.000836	0.000836	CcSEcCtD
Aztreonam—Paraesthesia—Epirubicin—urinary bladder cancer	0.00083	0.00083	CcSEcCtD
Aztreonam—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000827	0.000827	CcSEcCtD
Aztreonam—Dyspnoea—Epirubicin—urinary bladder cancer	0.000824	0.000824	CcSEcCtD
Aztreonam—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000814	0.000814	CcSEcCtD
Aztreonam—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000807	0.000807	CcSEcCtD
Aztreonam—Hypotension—Doxorubicin—urinary bladder cancer	0.000799	0.000799	CcSEcCtD
Aztreonam—Pain—Epirubicin—urinary bladder cancer	0.00079	0.00079	CcSEcCtD
Aztreonam—Urticaria—Methotrexate—urinary bladder cancer	0.000784	0.000784	CcSEcCtD
Aztreonam—Abdominal pain—Methotrexate—urinary bladder cancer	0.000781	0.000781	CcSEcCtD
Aztreonam—Body temperature increased—Methotrexate—urinary bladder cancer	0.000781	0.000781	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000779	0.000779	CcSEcCtD
Aztreonam—Insomnia—Doxorubicin—urinary bladder cancer	0.000773	0.000773	CcSEcCtD
Aztreonam—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000768	0.000768	CcSEcCtD
Aztreonam—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000762	0.000762	CcSEcCtD
Aztreonam—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000761	0.000761	CcSEcCtD
Aztreonam—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000756	0.000756	CcSEcCtD
Aztreonam—Urticaria—Epirubicin—urinary bladder cancer	0.000734	0.000734	CcSEcCtD
Aztreonam—Pain—Doxorubicin—urinary bladder cancer	0.000731	0.000731	CcSEcCtD
Aztreonam—Abdominal pain—Epirubicin—urinary bladder cancer	0.00073	0.00073	CcSEcCtD
Aztreonam—Body temperature increased—Epirubicin—urinary bladder cancer	0.00073	0.00073	CcSEcCtD
Aztreonam—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000728	0.000728	CcSEcCtD
Aztreonam—Asthenia—Methotrexate—urinary bladder cancer	0.000708	0.000708	CcSEcCtD
Aztreonam—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000705	0.000705	CcSEcCtD
Aztreonam—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000699	0.000699	CcSEcCtD
Aztreonam—Pruritus—Methotrexate—urinary bladder cancer	0.000699	0.000699	CcSEcCtD
Aztreonam—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000681	0.000681	CcSEcCtD
Aztreonam—Urticaria—Doxorubicin—urinary bladder cancer	0.000679	0.000679	CcSEcCtD
Aztreonam—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000676	0.000676	CcSEcCtD
Aztreonam—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000676	0.000676	CcSEcCtD
Aztreonam—Diarrhoea—Methotrexate—urinary bladder cancer	0.000676	0.000676	CcSEcCtD
Aztreonam—Asthenia—Epirubicin—urinary bladder cancer	0.000663	0.000663	CcSEcCtD
Aztreonam—Pruritus—Epirubicin—urinary bladder cancer	0.000654	0.000654	CcSEcCtD
Aztreonam—Dizziness—Methotrexate—urinary bladder cancer	0.000653	0.000653	CcSEcCtD
Aztreonam—Diarrhoea—Epirubicin—urinary bladder cancer	0.000632	0.000632	CcSEcCtD
Aztreonam—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00063	0.00063	CcSEcCtD
Aztreonam—Vomiting—Methotrexate—urinary bladder cancer	0.000628	0.000628	CcSEcCtD
Aztreonam—Rash—Methotrexate—urinary bladder cancer	0.000623	0.000623	CcSEcCtD
Aztreonam—Dermatitis—Methotrexate—urinary bladder cancer	0.000622	0.000622	CcSEcCtD
Aztreonam—Headache—Methotrexate—urinary bladder cancer	0.000619	0.000619	CcSEcCtD
Aztreonam—Asthenia—Doxorubicin—urinary bladder cancer	0.000613	0.000613	CcSEcCtD
Aztreonam—Dizziness—Epirubicin—urinary bladder cancer	0.000611	0.000611	CcSEcCtD
Aztreonam—Pruritus—Doxorubicin—urinary bladder cancer	0.000605	0.000605	CcSEcCtD
Aztreonam—Vomiting—Epirubicin—urinary bladder cancer	0.000588	0.000588	CcSEcCtD
Aztreonam—Nausea—Methotrexate—urinary bladder cancer	0.000587	0.000587	CcSEcCtD
Aztreonam—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000585	0.000585	CcSEcCtD
Aztreonam—Rash—Epirubicin—urinary bladder cancer	0.000583	0.000583	CcSEcCtD
Aztreonam—Dermatitis—Epirubicin—urinary bladder cancer	0.000582	0.000582	CcSEcCtD
Aztreonam—Headache—Epirubicin—urinary bladder cancer	0.000579	0.000579	CcSEcCtD
Aztreonam—Dizziness—Doxorubicin—urinary bladder cancer	0.000565	0.000565	CcSEcCtD
Aztreonam—Nausea—Epirubicin—urinary bladder cancer	0.000549	0.000549	CcSEcCtD
Aztreonam—Vomiting—Doxorubicin—urinary bladder cancer	0.000544	0.000544	CcSEcCtD
Aztreonam—Rash—Doxorubicin—urinary bladder cancer	0.000539	0.000539	CcSEcCtD
Aztreonam—Dermatitis—Doxorubicin—urinary bladder cancer	0.000539	0.000539	CcSEcCtD
Aztreonam—Headache—Doxorubicin—urinary bladder cancer	0.000536	0.000536	CcSEcCtD
Aztreonam—Nausea—Doxorubicin—urinary bladder cancer	0.000508	0.000508	CcSEcCtD
